Use fundamental data analysis to confirm all available indicators of Virtus LifeSci Biotech to find out if markets are presently mispricing the entity. We found ten available drivers for Virtus LifeSci Biotech Products ETF which can be compared to its competition. Please use Virtus LifeSci Price to Earning, Total Asset as well as the relationship between Total Asset and Equity Positions Weight to make a decision on weather Virtus LifeSci Biotech is priced fairly. Use Virtus LifeSci to enhance returns of your portfolios. The etf experiences normal upward fluctuation. Check odds of Virtus LifeSci to be traded at $43.22 in 30 days
Virtus LifeSci Company Summary
Virtus LifeSci competes with Davis Select, Global X, ARK Israeli, Credit Suisse, and PPLN. Virtus LifeSci Biotech Products ETF is USA based ETF administrated by Virtus ETF Solutions LLC. The ETF is issued and managed by BioShares, and composed of 85 constituents. The fund currently manages 35 M in total asset with 0.79 percent management fee and under 0.79 percent of total fund expense. Virtus LifeSci Biotech Products ETF invests mostly in Developed Markets around North America and is publically traded since December 17, 2014.
Virtus LifeSci Biotech Products ETF is third largest ETF in one year return as compared to similar ETFs. It is the top ETF in price to book as compared to similar ETFs fabricating about 0.17 of Price to Book per One Year Return. The ratio of One Year Return to Price to Book for Virtus LifeSci Biotech Products ETF is roughly 5.75
Virtus LifeSci Biotech Systematic Risk
The output start index for this execution was twenty with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Virtus LifeSci Biotech correlated with the market. If Beta is less than 0 Virtus LifeSci generally moves in the opposite direction as compared to the market. If Virtus LifeSci Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Virtus LifeSci Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Virtus LifeSci is generally in the same direction as the market. If Beta > 1 Virtus LifeSci moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.
Virtus LifeSci Financial Distress Probability
Chance of Financial Distress
Virtus LifeSci Biotech Products ETF has less than 1 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info